Advertisement

Topics

Latest Gastroenterology NewsRSS

07:00 EST 23rd February 2017 | BioPortfolio

IFM Therapeutics Appoints Renowned Physicians from Academia and Industry to Clinical Advisory Board

Advisors include internationally recognized immunologists and oncologists IFM Therapeutics, a biopharmaceutical company developing a portfolio of first-in-class small molecules targeting the innate immune system for the treatment of cancer and inflammatory disease, today announced the appointment of seven leading physicians to its clinical advisory boa...

CANCER du SEIN : L'exercice physique, la plus bénéfique des options pour la récupération - Canadian Medical Association Journal

Ce n'est pas la première étude à prôner l'exercice pour la récupération du cancer du sein, en particulier par la réduction de l'inflammation du tissu mammaire. Elle confirme que 30 mn d'activité d'intensité modérée, du type marche, peut contribuer à empêcher la récidive et limiter le décès...

"Sometimes saving lives justifies crony capitalism"

Bar-Ilan University biologist Prof. Izhak Haviv insists personalized medicine to cure cancer in affluent people will help all patients.

STAT Plus: First Look: Lab-grown voice boxes aim to offer a new option for larynx cancer patients

Laryngeal cancer will cost some patients all or part of their voice boxes — but new research using stem cells aims to grow new larynges right in the lab.

Shire Launches 'Rare Count' Campaign to Personalize the Global Impact of Rare Diseases

LEXINGTON, Mass., February 23, 2017 /PRNewswire/ -- - For Every 'Count', Shire Will Donate to Leading Rare Disease Organizations   - Campaign Honoring Rare Disease Day Open to All at http://www.shire.com/RareCount  Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the launch of 'Rare Count' in honor of Rare Disease Day and the 350 million people worldwide living with rare di...

Continental Who's Who recognizes Debbie M. Barrett-Bryson, RN, MSN-Ed, MHA, RNC-OB, CCE, CCM

GOODYEAR, Ariz., Feb. 22, 2017 /PRNewswire/ -- Continental Who's Who recognizes Debbie M. Barrett-Bryson, RN, MSN-Ed, MHA, RNC-OB, CCE, CCM, as a Pinnacle Lifetime Member in recognition of her work in the Healthcare Education and Nursing fields. Barrett-Bryson serves as a full-time Professor at the University of Phoenix as a member of the Nursing faculty. "When I was promoted to the Regional ...

Morris Animal Foundation Receives $1 Million Grant for Bone Cancer Studies

The Petco Foundation and the Blue Buffalo Foundation have partnered to sponsor a $1 million grant for Morris Animal Foundation to help fund the Foundation’s research initiative in osteosarcoma, the most common bone cancer in dogs. “Morris Animal Foundation continues to invest in groundbreaking osteosarcoma research, and we are deeply appreciat...

FDA shuts down Louisiana company for selling adulterated supplements

Michael JohnsenThe defendants marketed their products with claims that they could treat medical conditions such as cancer, cardiovascular disease, multiple sclerosis, autism, bipolar disorder, brain injury and epilepsy. read more

Secukinumab does not increase IBD incidence in patients with psoriasis, spondyloarthropathies

Reports of Crohn’s disease and ulcerative colitis among patients with psoriasis, psoriatic arthritis or ankylosing spondylitis treated with secukinumab were infrequent and consistent with earlier findings, according to data presented at the American College of Rheumatology Annual Meeting.“We looked at the onset of inflammatory bowel disease (IBD) in patients with psoriasis, psoriatic arthritis...

Exercise 'most proven method' to prevent return of breast cancer

"A half hour stroll a day can help women who've survived breast cancer prevent the killer disease returning," The Sun reports. A review of recent evidence, carried out by Canadian researchers, was prompted by the fact that many women who undergo treatment for breast cancer are eager to make lifestyle changes that may help reduce the risk of the cancer returning. But there is a great dea...

Walgreens designates more than 50 specialty pharmacies as cancer-specialized centers

Michael JohnsenThe pharmacy staff at cancer-specialized specialty pharmacies have completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers. read more

Walgreens specializes in cancer care across 50 specialty pharmacy locations

Michael JohnsenThe pharmacy staff at cancer-specialized specialty pharmacies have completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers. read more

Walgreens Designates more than 50 Specialty Pharmacies as Cancer-Specialized Locations

Collaborations with The Leukemia & Lymphoma Society, Oncology Nursing Society and others provide cancer-focused continuing education for Walgreens specialty pharmacy staff Furthering its commitment to personalized patient care and continuing education for its pharmacy staff, Walgreens has designated more than 50 of its local specialty pharmacies as...

Analyzing Various Molecular Subtypes in Bladder Cancer

Dr. Roland Seiler presented an analysis of how different bladder cancer molecular subtypes respond to neoadjuvant chemotherapy at the 2017 ASCO Genitourinary Cancer Symposium.

Saddleback Memorial Medical Center Named One of America's 50 Best Hospitals by Healthgrades for Third Consecutive Year

LAGUNA HILLS, Calif., Feb. 22, 2017 /PRNewswire-USNewswire/ -- For the third consecutive year, Saddleback Memorial Medical Center received Healthgrades 2017 America's 50 Best Hospitals Award™. The distinction places Saddleback Memorial in the top 1% of more than 4,500 hospitals nationwide for consistent, year-over-year superior clinical performance as measured by Healthgrades, the leading o...

Parkinson Disease - Market Insights, Epidemiology and Market Forecast 2023 - 7MM

LONDON, Feb. 22, 2017 /PRNewswire/ -- ght's "Parkinson Disease - Market Insights, Epidemiology and Market Forecast – 2023 - 7MM" Reports provides an overview of the disease and global market size of the Parkinson Disease for the 7MM. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Parkinson Disease from 2010-2023. According to Publisher...

#news #biotech ImmusanT’s celiac disease immunotherapy passes first clinical test

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ImmusanT’s celiac disease immunotherapy passes first clinical test .ImmusanT’s celiac disease immunotherapy passes first clinical test phil Wed, 02/22/2017 – 09:30 from Feed http://ift.tt/2lvsl1A Cet article #news #biotech ImmusanT’s celiac disease immu...

Colorectal Cancer - Heat Map and Analysis

LONDON, Feb. 22, 2017 /PRNewswire/ -- SummaryColorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in the form of a small polyp within the colon or rectum. It rarely occurs in the absence of ...

DMC: little promise for Argos cancer therapy

Argos stock plummeted more than 66% on news that an independent data monitoring committee recommended stopping a Phase 3 study of its cancer drug.

Atreca, Inc. Presents New Preclinical Findings for Novel Cancer Immunotherapy Platform at Molecular Medicine Tri-Conference 2017

Atreca’s Immune Repertoire Capture® Platform Generates Potent Antibodies Targeting Multiple Tumor Types Atreca Antibody Eliminates Tumor in In Vivo Preclinical Model Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced tod...

Celltrion's MabThera cleared by EC for autoimmune diseases and cancer

The European Commission has approved Celltrion Healthcare’s rituximab biosimilar – Truxima (CT-P10) – for the same autoimmune disease and cancer indications as the reference product.

Understanding the Cancer-Immune Set Point

One of the frequently cited conceptual frameworks in Cancer Immunotherapy is the Cancer Immunity Cycle developed by Drs Dan Chen…

Right Upper Quadrant Pain in Abdomen of 60-Year-Old Patient

A 60-year-old woman presents with vague abdominal pain in the right upper quadrant. An ultrasound reveals a gallbladder abnormality. Based on the images from the abdomen MRI, what is the diagnosis?

Cue Biopharma Strengthens Scientific and Clinical Advisory Board with Leading Oncology and Immunology Experts

Cue Biopharma, Inc. (Cue), an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease, announced the appointment of three new key opinion leaders to its scientific/clinical advisory board (SAB). The new memb

First-Ever Heart Valve Disease Awareness Day Puts Condition in National Spotlight

The Alliance for Aging Research announces National Heart Valve Disease Awareness Day debuts on February 22. Its four core messages: Listen to your body, know your risk factors, get your heart checked regularly, and spread the word and raise awareness. Washington, D.C. (PRWEB) February 22, 2017 The first-ever National Heart Valve Disease Awareness Day is being celebrated throughout the country tod...

Quick Search
Advertisement
 

review and buy Gastroenterology market research data and corporate reports here